Author:
Borde Johannes P.,Zajkowska Joanna
Abstract
TBE is the most important tick-borne arbovirus disease of humans. Epidemiological data indicate a trend towards an increasing severity with higher age.
A number of possible genetic and non-genetic risk factors have been identified, which might have an impact on the manifestation and severity of human disease.
Different TBEV strains seem to cause differing clinical courses of disease. While the TBE-EU mainly causes a biphasic course, the clinical course of TBEV-FE and TBEV-SIB are mainly monophasic.
The diagnosis of TBE is based on serological tests.
So far there is no effective treatment of TBEV infections.
Publisher
Global Health Press Pte Ltd
Reference84 articles.
1. Kaiser R. Frühsommer-Meningoe Nervenarzt. 2016;87:667-80.
2. Bogovic P, Strle F. Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management. World J Clin Cases. 2015;3:430.
3. Epidemiological situation of tick-borne encephalitis in the European Union and Europe Free Trade Association countries. ECDC technical report. 2012.
4. Czupryna P, Moniuszko A, Pancewicz SA, Grygorczuk S, Kondrusik M, Zajkowska J. Tick-borne encephalitis in Poland in years 1993-2008–epidemiology and clinical presentation. A retrospective study of 687 patients. Eur J Neurol. 2011;18:673-9.
5. Lipowski D, Popiel M, Perlejewski K, et al. A Cluster of Fatal Tick-borne Encephalitis Virus Infection in Organ Transplant Setting. J Infect Dis. 2017;215:896-901.